Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07567157

The Therapeutic Effect of Expressive Writing.

Led by Royal Cornwall Hospitals Trust · Updated on 2026-05-05

50

Participants Needed

1

Research Sites

18 weeks

Total Duration

On this page

Sponsors

R

Royal Cornwall Hospitals Trust

Lead Sponsor

U

University of Plymouth

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to understand the impact of compassionate expressive writing in people living with and beyond cancer. The main question it aims to answer is: Does compassionate expressive writing have any impact on well-being outcomes in people living with and beyond cancer, such as body compassion, self-compassion, quality of life and psychological well-being outcomes ? Researchers will compare compassionate expressive writing with a standard expressive writing task (with no compassionate prompt) to see if there is a difference in self-reported body compassion, self-compassion, quality of life and psychological well-being outcomes between the two conditions. Participants will : Complete a series of pre-intervention questionnaires. Be assigned to one of the two writing conditions. Attend four expressive writing sessions and write freely for approximately 20 minutes in response to a topic related to their cancer experience. Complete a series of post-intervention questionnaires. Repeat the questionnaires at 1-month follow-up.

CONDITIONS

Official Title

The Therapeutic Effect of Expressive Writing.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • To have experienced an internal or external change to their body due to any form of cancer and/or its treatment at any point in their lives.
  • To be 18 or older.
  • The ability to read and write in English.
  • To have the ability to provide informed consent.
Not Eligible

You will not qualify if you...

  • Distress levels that make participation safe or inappropriate due to cancer prognosis or a mental health condition. (This is flagged by the score on the IES questionnaire.)
  • Inability to realistically commit to a 4-week intervention due to poor physical or mental health or other personal commitments.
  • Inability to provide informed consent.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Royal Cornwall Hospital NHS Trust

Truro, Cornwall, United Kingdom, TR1 3HD

Actively Recruiting

Loading map...

Research Team

A

Ariane Scalpello, Doctoral

CONTACT

R

RCHT Sponsor RCHT Sponsor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here